171 related articles for article (PubMed ID: 23468424)
1. Antagonism to human BST-2/tetherin by Sendai virus glycoproteins.
Bampi C; Rasga L; Roux L
J Gen Virol; 2013 Jun; 94(Pt 6):1211-1219. PubMed ID: 23468424
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Sendai virus persistently infected L929 cells and Sendai virus pi strain: recombinant Sendai viruses having Mpi protein shows lower cytotoxicity and are incapable of establishing persistent infection.
Nishio M; Tsurudome M; Ito M; Kawano M; Komada H; Ito Y
Virology; 2003 Sep; 314(1):110-24. PubMed ID: 14517065
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2.
Kong WS; Irie T; Yoshida A; Kawabata R; Kadoi T; Sakaguchi T
Hiroshima J Med Sci; 2012 Sep; 61(3):59-67. PubMed ID: 23077864
[TBL] [Abstract][Full Text] [Related]
4. Sendai virus particle production: a more detailed role of F and HN through, namely, their association with M.
Shevtsova-Horoz A; Essaidi-Laziosi M; Roux L
Virus Res; 2015 Mar; 199():31-41. PubMed ID: 25613008
[TBL] [Abstract][Full Text] [Related]
5. BST-2 restricts IAV release and is countered by the viral M2 protein.
Hu S; Yin L; Mei S; Li J; Xu F; Sun H; Liu X; Cen S; Liang C; Li A; Guo F
Biochem J; 2017 Feb; 474(5):715-730. PubMed ID: 28087685
[TBL] [Abstract][Full Text] [Related]
6. Characterization of temperature-sensitive HVJ (Sendai virus) infection in Vero cells: inhibitory mechanism of viral production at 41 degrees.
Hirayama E; Ishida Y; Sugimoto M; Hiraki A; Kim J
Intervirology; 2003; 46(2):86-95. PubMed ID: 12684547
[TBL] [Abstract][Full Text] [Related]
7. Nontransmissible virus-like particle formation by F-deficient sendai virus is temperature sensitive and reduced by mutations in M and HN proteins.
Inoue M; Tokusumi Y; Ban H; Kanaya T; Tokusumi T; Nagai Y; Iida A; Hasegawa M
J Virol; 2003 Mar; 77(5):3238-46. PubMed ID: 12584347
[TBL] [Abstract][Full Text] [Related]
8. The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation.
Janvier K; Pelchen-Matthews A; Renaud JB; Caillet M; Marsh M; Berlioz-Torrent C
PLoS Pathog; 2011 Feb; 7(2):e1001265. PubMed ID: 21304933
[TBL] [Abstract][Full Text] [Related]
9. [Cloning and expression of the six coding genes of sendai virus BB1 strain].
Zhang HF; Yang Y; Dong XY; Wu XB
Bing Du Xue Bao; 2009 May; 25(3):213-9. PubMed ID: 19634765
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the TYTLE motif in the cytoplasmic tail of the sendai virus fusion protein deeply affects viral assembly and particle production.
Essaidi-Laziosi M; Shevtsova A; Gerlier D; Roux L
PLoS One; 2013; 8(12):e78074. PubMed ID: 24339863
[TBL] [Abstract][Full Text] [Related]
11. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M
J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365
[TBL] [Abstract][Full Text] [Related]
12. A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus.
Zimmer G; Bossow S; Kolesnikova L; Hinz M; Neubert WJ; Herrler G
J Virol; 2005 Aug; 79(16):10467-77. PubMed ID: 16051839
[TBL] [Abstract][Full Text] [Related]
13. Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo.
Sanderson CM; Wu HH; Nayak DP
J Virol; 1994 Jan; 68(1):69-76. PubMed ID: 8254778
[TBL] [Abstract][Full Text] [Related]
14. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus.
Kobayashi M; Iida A; Ueda Y; Hasegawa M
J Virol; 2003 Feb; 77(4):2607-14. PubMed ID: 12551999
[TBL] [Abstract][Full Text] [Related]
15. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
[TBL] [Abstract][Full Text] [Related]
16. Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.
Serra-Moreno R; Zimmermann K; Stern LJ; Evans DT
PLoS Pathog; 2013; 9(7):e1003487. PubMed ID: 23853598
[TBL] [Abstract][Full Text] [Related]
17. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV
J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779
[TBL] [Abstract][Full Text] [Related]
18. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.
Zhan X; Slobod KS; Krishnamurthy S; Luque LE; Takimoto T; Jones B; Surman S; Russell CJ; Portner A; Hurwitz JL
Vaccine; 2008 Jun; 26(27-28):3480-8. PubMed ID: 18499307
[TBL] [Abstract][Full Text] [Related]
19. Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein.
Ali A; Nayak DP
Virology; 2000 Oct; 276(2):289-303. PubMed ID: 11040121
[TBL] [Abstract][Full Text] [Related]
20. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
Vigan R; Neil SJ
J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
